Anterograde and retrograde isolated lung perfusion (ILP) with doxorubicin in the rat: comparison of pharmacokinetics and toxicity

T. Krueger, A. Kümmerle, C. Vallet, Y. Pan, L. Decosterd, H. B. Ris (Lausanne, Switzerland)

Source: Annual Congress 2002 - Isolated lung perfusion and lung cancer
Session: Isolated lung perfusion and lung cancer
Session type: Oral Presentation
Number: 1150
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Krueger, A. Kümmerle, C. Vallet, Y. Pan, L. Decosterd, H. B. Ris (Lausanne, Switzerland). Anterograde and retrograde isolated lung perfusion (ILP) with doxorubicin in the rat: comparison of pharmacokinetics and toxicity. Eur Respir J 2002; 20: Suppl. 38, 1150

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Survival and pharmacokinetics of gemcitabine in a rat model of isolated lung perfusion
Source: Eur Respir J 2002; 20: Suppl. 38, 179s
Year: 2002

Experimental retrograde single-pass isolated lung perfusion (SP-ILP) affords homogeneous drug distribution to the lung
Source: Eur Respir J 2001; 18: Suppl. 33, 14s
Year: 2001

Acute effects of cisplatin on mucociliary function: In vitro measurements
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010


Flow, perfusion time and the concentration of perfusate do not influence the final concentration of melphalan in the lung after isolated lung perfusion in rats
Source: Eur Respir J 2002; 20: Suppl. 38, 179s
Year: 2002

Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administration
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017


Assessment of lung deposition and pharmacokinetics in 12 lung transplanted patients after inhalation of a novel liposomal ciclosporin a (CsA) formulation by the eFlow electronic nebuliser
Source: Eur Respir J 2007; 30: Suppl. 51, 29s
Year: 2007

Combination chemotherapy with gemcitabine using isolated lung perfusion for the treatment of lung metastases
Source: Eur Respir J 2004; 24: Suppl. 48, 42s
Year: 2004

Therapeutic effectiveness of early and late surfactant-BL administration in bleomycine induced injury of lung in rats
Source: Eur Respir J 2003; 22: Suppl. 45, 532s
Year: 2003

Inhaled liposomal treprostinil (L606) shows extended release in healthy volunteer, as well as prolongs pharmacological effect in hypoxia-induced rat.
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Effect of pulse therapy with glucocorticoid and cyclophosphamide on lung fibrosis due to paraquat poisoning in rat
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010


Intrapleural administration of pemetrexed: a pharmacokinetic study in an animal model
Source: Annual Congress 2008 - Treatment of thoracic tumours
Year: 2008

Pegylated liposomal doxorubicin HCl (Caelyx) in combination with sandostatin LAR as salvage therapy in patients with small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 78s
Year: 2005

Antimicrobial properties of aerosolized liposomal cyclosporine (L-CsA) in lung transplantation patients – An in vitro study
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010

The first-pass effect of gemcitabine during selective pulmonary artery perfusion using blood flow occlusion
Source: Eur Respir J 2003; 22: Suppl. 45, 367s
Year: 2003

Advantage of retrograde flush perfusion with low potassium dextran solution for preservation in lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 178s
Year: 2001

Improved pulmonary resistance in healthy sheep following Targeted lung denervation (TLD)
Source: International Congress 2017 – Endoscopic lung volume reduction (EVLR) and targeted lung denervation (TLD)
Year: 2017

Laninamivir’s prolonged intrapulmonary retention: Intrapulmonary pharmacokinetics (PK) and the intracellular disposition to support the long-lasting efficacy after an inhaled administration of its prodrug laninamivir octanoate (LO)
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


Effect of long-term imatinib treatment in a severe preclinical PAH rat model: An insight into pulmonary perfusion using a novel casting method
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012


A multicompartmemt lung model predicts pulmonary pharmacokinetics of inhaled liposomal treprostinil (L606) in healthy volunteer
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021

Gemcitabine induced pulmonary toxicity with late oncet
Source: Eur Respir J 2006; 28: Suppl. 50, 382s
Year: 2006